Coronavirus Pfizer Germany covid-19 vaccine Coronavirus Pfizer Germany

Pfizer applies for emergency coronavirus vaccine approval in U.S.

globalnews.ca

Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic — but not until after a long, hard winter.The action comes days after Pfizer Inc.

and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News